Arcium (ARX) is 133.2× the size of Biometric Financial (BIOFI) by market capitalisation. Their daily returns move barely together (correlation 0.14 across 45 shared trading days). Both have run at a similar volatility, around 117% annualised.
BIOFIARX
0.14over 45 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | BIOFI | ARX |
|---|---|---|
| Max drawdown (400d) | -79.4% | -19.7% |
| Risk-adjusted return (90d) | -0.40 | 0.58 |
| Best 30 days (past year) | +70.6% | — |
| Worst 30 days (past year) | -54.2% | — |
Relative strength over 90 days: ARX outperformed BIOFI by 66.2% — measured on the BIOFI/ARX ratio, so it holds regardless of market direction.